103 related articles for article (PubMed ID: 15829545)
1. C-reactive protein levels and outcomes after statin therapy.
Cohen B; Singh D
N Engl J Med; 2005 Apr; 352(15):1603-5; author reply 1603-5. PubMed ID: 15829545
[No Abstract] [Full Text] [Related]
2. C-reactive protein levels and outcomes after statin therapy.
Jaber BL; Madias NE
N Engl J Med; 2005 Apr; 352(15):1603-5; author reply 1603-5. PubMed ID: 15832451
[No Abstract] [Full Text] [Related]
3. C-reactive protein levels and outcomes after statin therapy.
Greenland P; Lloyd-Jones DM; Moss AJ
N Engl J Med; 2005 Apr; 352(15):1603-5; author reply 1603-5. PubMed ID: 15832450
[No Abstract] [Full Text] [Related]
4. Relation of C-reactive protein and one-year survival after acute myocardial infarction with versus without statin therapy.
Kinjo K; Sato H; Sakata Y; Nakatani D; Mizuno H; Shimizu M; Nishino M; Ito H; Tanouchi J; Nanto S; Hori M;
Am J Cardiol; 2005 Sep; 96(5):617-21. PubMed ID: 16125481
[TBL] [Abstract][Full Text] [Related]
5. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
[TBL] [Abstract][Full Text] [Related]
6. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?
Goyal A; Blazing M
Am Heart J; 2005 Oct; 150(4):650-1. PubMed ID: 16209959
[No Abstract] [Full Text] [Related]
7. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
[TBL] [Abstract][Full Text] [Related]
8. Targeting patients for statin therapy for the primary prevention of vascular events: what is the best approach?
Mahoney EM
Circulation; 2010 Oct; 122(15):1446-8. PubMed ID: 20876432
[No Abstract] [Full Text] [Related]
9. Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO survey.
Sicard P; Zeller M; Dentan G; Laurent Y; Touzery C; L'huillier I; Janin-Manificat L; Lorgis L; Beer JC; Makki H; Rochette L; Cottin Y;
Am J Hypertens; 2007 Nov; 20(11):1133-9. PubMed ID: 17954357
[TBL] [Abstract][Full Text] [Related]
10. Early effects of statins in patients with coronary artery disease and high C-reactive protein.
Muhlestein JB; Anderson JL; Horne BD; Carlquist JF; Bair TL; Bunch TJ; Pearson RR;
Am J Cardiol; 2004 Nov; 94(9):1107-12. PubMed ID: 15518602
[TBL] [Abstract][Full Text] [Related]
11. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
[TBL] [Abstract][Full Text] [Related]
12. Drug insight: Statin use in the elderly.
Raffel OC; White HD
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
[TBL] [Abstract][Full Text] [Related]
13. The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.
Chin J
S D Med; 2009 Mar; 62(3):104-6. PubMed ID: 19480274
[No Abstract] [Full Text] [Related]
14. [Statin therapy is a basic treatment for coronary heart disease].
Gurevich MA
Klin Med (Mosk); 2003; 81(12):60-2. PubMed ID: 14971160
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
16. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
[TBL] [Abstract][Full Text] [Related]
17. [Fewer myocardial infarcts. Statin therapy is even effective in the elderly].
MMW Fortschr Med; 2003 Mar; 145(11):58. PubMed ID: 12688200
[No Abstract] [Full Text] [Related]
18. C-reactive protein in 2005. Interview by Peter C. Block.
Ridker PM
J Am Coll Cardiol; 2005 Jul; 46(1):CS2-5. PubMed ID: 16007748
[TBL] [Abstract][Full Text] [Related]
19. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery.
Pascual DA; Arribas JM; Tornel PL; Marín F; Oliver C; Ahumada M; Gomez-Plana J; Martínez P; Arcas R; Valdes M
Ann Thorac Surg; 2006 Jan; 81(1):78-83. PubMed ID: 16368340
[TBL] [Abstract][Full Text] [Related]
20. Statins. Cholesterol lowering and beyond.
Mayo Clin Womens Healthsource; 2006 Jun; 10(6):1-2. PubMed ID: 16675916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
